Yang tonifying and recuperating pill

Abstract

The invention discloses a yang tonifying and rejuvenating pill which is characterized by comprising the following components by mass: 55-230 g of astragalus membranaceus, 5-7 g of radix angelicae lateralis preparata, 4-5 g of radix paeoniae rubra, 2-4 g of lumbricus, 2-4 g of ligusticum wallichii, 2-4 g of safflower and 2-4 g of peach kernel. The components are mixed into pills through microcrystallization and wall breaking. The formula is simple, the cost can be reduced, and by adopting the components, the formed pill does not contain sugar, so that the pill is suitable for different patients to use, the application range of the pill can be improved, long-time and specific boiling requirements are not needed, the processing and manufacturing efficiency can be reduced, and the cost can be reduced. Meanwhile, the utilization rate of the components is increased, the applicability is high, and the practicability is good.

Description

Technical Field

[0001] The invention belongs to the technical field of medicines, and particularly relates to a Buyang Huanwu Pill. Background Art

[0002] Buyang Huanwu Pills is an excellent medicine for treating acute attacks of stroke. It originates from the corresponding medicine in "Treatise on Febrile Diseases and Miscellaneous Diseases" by Zhang Zhongjing in ancient times. Wang Qingren, a famous medical scientist in the Qing Dynasty, formally proposed the compatibility principle of Buyang Buyu Decoction in his work "Medical Errors Correction". This prescription combines the characteristics of Taohong Siwu Decoction and Danggui Buyue Decoction, and is mainly aimed at the symptoms of qi deficiency and blood stasis.

[0003] However, the formula of traditional Buyang Huanwu Pills is relatively limited, making it difficult to achieve the desired medicinal effect. At the same time, it requires a long time to boil and has specific boiling requirements, which greatly reduces its utilization rate, and therefore its practicality is limited. Summary of the invention

[0004] The purpose of the invention is to provide a Buyang Huanwu pill which is beneficial to improving the drug efficacy.

[0005] The technical solution to achieve the purpose of the present invention is a Buyang Huanwu Pill, which includes the following components:

[0006] Astragalus 55-230g, Radix Angelicae Sinensis 5-7g, Radix Paeoniae Rubra 4-5g, Pheretima Root 2-4g, Rhizoma Chuanxiong 2-4g, Carthamus tinctorius 2-4g, Semen Persicae 2-4g;

[0007] The above components are mixed into pellets through microcrystallization and wall breaking.

[0008] More preferably, the composition further comprises 2-4 g of Codonopsis pilosula or 2-4 g of Salvia miltiorrhiza.

[0009] More preferably, the composition comprises the following qualities:

[0010] Astragalus 60-200g, Radix Angelicae Sinensis 6g, Radix Paeoniae Rubra 4.5g, Pheretima Root 3g, Rhizoma Chuanxiong 3g, Flos Carthami 3g, Peach Kernel 3g;

[0011] The above components are mixed into pellets through microcrystallization and wall breaking.

[0012] More preferably, the composition further comprises 3g of Codonopsis pilosula or 3g of Salvia miltiorrhiza.

[0013] When used, during the acute attack period, a course of treatment is 15 days, 2 tablets per day;

[0014] During the recovery period, one course of treatment is 3-6 months, one tablet every 3 days;

[0015] During processing, every 200g of active ingredients are concentrated and refined into 3g pills.

[0016] The present invention has positive effects: the formula of the present invention is simple, which is conducive to reducing costs, and the above-mentioned components are used to make the formed pills free of sugar, so that they are suitable for use by different patients, which is conducive to improving their application range, and does not require long-term and specific boiling requirements, which is conducive to reducing the efficiency of processing and manufacturing, and is also conducive to improving the utilization rate of the components, and has strong applicability and good practicality. DETAILED DESCRIPTION

[0017] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0018] Example

[0019] A Buyang Huanwu Pill comprises the following components: 55-230g of Astragalus, 5-7g of Radix Angelicae Sinensis, 4-5g of Radix Paeoniae Rubrae, 2-4g of Pheretima, 2-4g of Rhizoma Chuanxiong, 2-4g of Carthamus tinctorius, and 2-4g of Semen Persicae; the above components are mixed into a pill shape through microcrystallization and wall breaking. In this embodiment, the microcrystals are fine chelated crystals. It can disintegrate quickly, thereby improving the processing efficiency and effect, and meets the national requirements for the disintegration rate of tablets. It also meets the requirements of international biological inspection and quarantine, and can pass the animal, plant and mineral quarantine and related regulations of customs in various countries around the world.

[0020] In actual application, 2-4g of Codonopsis pilosula or 2-4g of Salvia miltiorrhiza is also included.

[0021] In this embodiment, it includes the following components by weight: 60-200g of Astragalus, 6g of Radix Angelicae Sinensis, 4.5g of Radix Paeoniae Rubra, 3g of Pheretima, 3g of Rhizoma Chuanxiong, 3g of Carthamus Tinctorius, and 3g of Semen Persicae;

[0022] The above components are mixed into pellets through microcrystallization and wall breaking, and further include 3g of Codonopsis pilosula or 3g of Salvia miltiorrhiza.

[0023] When used, during the acute attack period, a course of treatment is 15 days, 2 tablets per day;

[0024] During the recovery period, one course of treatment is 3-6 months, one tablet every 3 days;

[0025] During processing, every 200g of active ingredients are concentrated and refined into 3g pills.

[0026] The present invention has positive effects: the formula of the present invention is simple, which is conducive to reducing costs, and the above-mentioned components are used to make the formed pills free of sugar, so that they are suitable for use by different patients, which is conducive to improving their application range, and does not require long-term and specific boiling requirements, which is conducive to reducing the efficiency of processing and manufacturing, and is also conducive to improving the utilization rate of the components, and has strong applicability and good practicality.

[0027] The standard parts used in this embodiment can be purchased directly from the market, and the non-standard structural components recorded in the specification can also be directly processed according to existing technical common sense. At the same time, the connection method of each component adopts the mature conventional means in the prior art, and the machinery, parts and equipment all adopt the conventional models in the prior art, so no specific description will be given here.

[0028] Obviously, the above embodiments of the present invention are merely examples for clearly explaining the present invention, and are not intended to limit the implementation methods of the present invention. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. However, these obvious changes or modifications derived from the essential spirit of the present invention still fall within the protection scope of the present invention.

Claims

1. A Buyang Huanwu Pill, characterized in that: The following quality ingredients are included: Astragalus 55-230g, Radix Angelicae Sinensis 5-7g, Radix Paeoniae Rubra 4-5g, Pheretima Root 2-4g, Rhizoma Chuanxiong 2-4g, Carthamus tinctorius 2-4g, Semen Persicae 2-4g; The above components are mixed into pellets through microcrystallization and wall breaking.

2. The Buyang Huanwu Pill according to claim 1, characterized in that: It also includes Codonopsis pilosula 2-4g or Salvia miltiorrhiza 2-4g.

3. The Buyang Huanwu Pill according to claim 2, characterized in that: The following quality ingredients are included: Astragalus 60-200g, Radix Angelicae Sinensis 6g, Radix Paeoniae Rubra 4.5g, Pheretima Root 3g, Rhizoma Chuanxiong 3g, Flos Carthami 3g, Peach Kernel 3g; The above components are mixed into pellets through microcrystallization and wall breaking.

4. The Buyang Huanwu Pill according to claim 3, characterized in that: It also includes Codonopsis pilosula 3g or Salvia miltiorrhiza 3g.